Weissbach Fabian H, Hirsch Hans H
Transplantation and Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.
Transplantation and Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland Division of Infection Diagnostics, Department of Biomedicine, University of Basel, Basel, Switzerland Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Clin Vaccine Immunol. 2015 Jul;22(7):754-60. doi: 10.1128/CVI.00096-15. Epub 2015 Apr 29.
Despite the availability of protective vaccines, tick-borne encephalitis virus (TBEV) infections have been increasingly reported to the European Centre for Disease Prevention and Control in the past 2 decades. Since the diagnosis of TBEV exposure relies on serological testing, we compared two commercial enzyme-linked immunosorbent assays (ELISAs), i.e., Immunozym FSME IgG assay (ELISA-1) and Euroimmun FSME Vienna IgG assay (ELISA-2). Both assays use whole TBEV antigens, but they differ in viral strains (Neudoerfl for ELISA-1 and K23 for ELISA-2) and cutoff values. In testing of samples from 398 healthy blood donors, ELISA-1 showed higher reactivity levels than ELISA-2 (P < 0.001), suggesting different assay properties. This finding was supported by Bland-Altman analysis of the optical density at 450 nm (OD450) (mean bias, +0.32 [95% limits of agreement, -0.31 to +0.95]) and persisted after transformation into Vienna units. Concordant results were observed for 276 sera (69%) (44 positive and 232 negative results). Discordant results were observed for 122 sera (31%); 15 were fully discordant, all being ELISA-1 positive and ELISA-2 negative, and 107 were partially discordant (101 being ELISA-1 indeterminate and ELISA-2 negative and 6 having positive or indeterminate reactivity in both ELISAs). Neutralization testing at a 1:10 dilution yielded positive results for 33 of 44 concordant positive sera, 1 of 15 fully discordant sera, and 1 of 33 partially discordant sera. Indirect immunofluorescence testing revealed high antibody titers of ≥100 for yellow fever virus in 18 cases and for dengue virus in one case, suggesting that cross-reactivity contributed to the ELISA-1 results. We conclude that (i) cross-reactivity among flaviviruses remains a limitation of TBEV serological testing, (ii) ELISA-2 revealed reasonable sensitivity and specificity for anti-TBEV IgG population screening of human sera, and (iii) neutralization testing is most specific and should be reserved for selective questions.
尽管有预防性疫苗,但在过去20年里,欧洲疾病预防控制中心接到的蜱传脑炎病毒(TBEV)感染报告却越来越多。由于TBEV暴露的诊断依赖于血清学检测,我们比较了两种商用酶联免疫吸附测定(ELISA),即Immunozym FSME IgG测定(ELISA - 1)和Euroimmun FSME维也纳IgG测定(ELISA - 2)。两种测定均使用全TBEV抗原,但它们在病毒株(ELISA - 1用Neudoerfl株,ELISA - 2用K23株)和临界值方面存在差异。在对398名健康献血者的样本进行检测时,ELISA - 1显示出比ELISA - 2更高的反应水平(P < 0.001),表明两种测定特性不同。450nm处光密度(OD450)的Bland - Altman分析支持了这一发现(平均偏差为 +0.32 [95%一致性界限,-0.31至 +0.95]),并且在转换为维也纳单位后仍然存在。276份血清(69%)的检测结果一致(44份阳性和232份阴性)。122份血清(31%)出现不一致结果;15份完全不一致,均为ELISA - 1阳性而ELISA - 2阴性,107份部分不一致(101份ELISA - 1结果不确定而ELISA - 2阴性,6份在两种ELISA中均呈阳性或结果不确定)。1:10稀释度的中和试验显示,44份一致阳性血清中的33份、15份完全不一致血清中的1份以及33份部分不一致血清中的1份呈阳性结果。间接免疫荧光检测显示,18例黄热病病毒抗体滴度≥100,1例登革热病毒抗体滴度≥100,这表明交叉反应影响了ELISA - 1的检测结果。我们得出以下结论:(i)黄病毒之间的交叉反应仍然是TBEV血清学检测的一个限制因素;(ii)ELISA - 2在人血清抗TBEV IgG群体筛查中显示出合理的敏感性和特异性;(iii)中和试验最为特异,应仅用于有选择性的问题。